These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16597593)

  • 1. A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis.
    Takahashi T; Takahashi K; Mernaugh RL; Tsuboi N; Liu H; Daniel TO
    Blood; 2006 Aug; 108(4):1234-42. PubMed ID: 16597593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotion of cell spreading and migration by vascular endothelial-protein tyrosine phosphatase (VE-PTP) in cooperation with integrins.
    Mori M; Murata Y; Kotani T; Kusakari S; Ohnishi H; Saito Y; Okazawa H; Ishizuka T; Mori M; Matozaki T
    J Cell Physiol; 2010 Jul; 224(1):195-204. PubMed ID: 20301196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the CD148-Interacting Region in Thrombospondin-1.
    Takahashi K; Sumarriva K; Kim R; Jiang R; Brantley-Sieders DM; Chen J; Mernaugh RL; Takahashi T
    PLoS One; 2016; 11(5):e0154916. PubMed ID: 27149518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD148 is a membrane protein tyrosine phosphatase present in all hematopoietic lineages and is involved in signal transduction on lymphocytes.
    de la Fuente-García MA; Nicolás JM; Freed JH; Palou E; Thomas AP; Vilella R; Vives J; Gayá A
    Blood; 1998 Apr; 91(8):2800-9. PubMed ID: 9531590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development.
    Takahashi T; Takahashi K; St John PL; Fleming PA; Tomemori T; Watanabe T; Abrahamson DR; Drake CJ; Shirasawa T; Daniel TO
    Mol Cell Biol; 2003 Mar; 23(5):1817-31. PubMed ID: 12588999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
    Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
    Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonistic anti-CD148 monoclonal antibody attenuates diabetic nephropathy in mice.
    Takahashi K; Kim RH; Pasic L; He L; Nagasaka S; Katagiri D; May T; Shimizu A; Harris RC; Mernaugh RL; Takahashi T
    Am J Physiol Renal Physiol; 2020 Mar; 318(3):F647-F659. PubMed ID: 31984788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cell-matrix adhesion.
    Jandt E; Denner K; Kovalenko M; Ostman A; Böhmer FD
    Oncogene; 2003 Jul; 22(27):4175-85. PubMed ID: 12833140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of receptor-type protein tyrosine phosphatase CD148 (HPTP eta/DEP-1) in Fc gamma receptor IIa signal transduction of human neutrophils.
    Hundt M; Schmidt RE
    Eur J Immunol; 1997 Dec; 27(12):3532-5. PubMed ID: 9464844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1.
    Palka HL; Park M; Tonks NK
    J Biol Chem; 2003 Feb; 278(8):5728-35. PubMed ID: 12475979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative regulation of human T cell activation by the receptor-type protein tyrosine phosphatase CD148.
    Tangye SG; Wu J; Aversa G; de Vries JE; Lanier LL; Phillips JH
    J Immunol; 1998 Oct; 161(8):3803-7. PubMed ID: 9780142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Endothelial SCUBE2 (Signal Peptide-CUB-EGF Domain-Containing Protein 2), a Novel VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) Coreceptor, Suppresses Tumor Angiogenesis.
    Lin YC; Liu CY; Kannagi R; Yang RB
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1202-1215. PubMed ID: 29545238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium-derived nitric oxide (NO) activates the NO-epidermal growth factor receptor-mediated signaling pathway in bradykinin-stimulated angiogenesis.
    Moraes MS; Costa PE; Batista WL; Paschoalin T; Curcio MF; Borges RE; Taha MO; Fonseca FV; Stern A; Monteiro HP
    Arch Biochem Biophys; 2014 Sep; 558():14-27. PubMed ID: 24960080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tyrosine phosphatase CD148 interacts with the p85 regulatory subunit of phosphoinositide 3-kinase.
    Tsuboi N; Utsunomiya T; Roberts RL; Ito H; Takahashi K; Noda M; Takahashi T
    Biochem J; 2008 Jul; 413(1):193-200. PubMed ID: 18348712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
    Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G
    Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression on human eosinophils of CD148: a membrane tyrosine phosphatase. Implications in the effector function of eosinophils.
    del Pozo V; Pirotto F; Cárdaba B; Cortegano I; Gallardo S; Rojo M; Arrieta I; Aceituno E; Palomino P; Gaya A; Lahoz C
    J Leukoc Biol; 2000 Jul; 68(1):31-7. PubMed ID: 10914487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.
    Grazia Lampugnani M; Zanetti A; Corada M; Takahashi T; Balconi G; Breviario F; Orsenigo F; Cattelino A; Kemler R; Daniel TO; Dejana E
    J Cell Biol; 2003 May; 161(4):793-804. PubMed ID: 12771128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine phosphorylation of DEP-1/CD148 as a mechanism controlling Src kinase activation, endothelial cell permeability, invasion, and capillary formation.
    Spring K; Chabot C; Langlois S; Lapointe L; Trinh NT; Caron C; Hebda JK; Gavard J; Elchebly M; Royal I
    Blood; 2012 Sep; 120(13):2745-56. PubMed ID: 22898603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of PTPs by H(2)O(2) regulates the activation of distinct MAPK pathways.
    Lee K; Esselman WJ
    Free Radic Biol Med; 2002 Oct; 33(8):1121-32. PubMed ID: 12374624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.